Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Patritumab Deruxtecan in Untreated Hormone Receptor-Positive/her2-negative Early Breast Cancer: Final Results from Part A of the Window-of-opportunity SOLTI TOT-HER3 Pre-Operative Study.

M. Oliveira,C. Falato,J. M. Cejalvo,M. Margeli Vila,P. Tolosa, F. J. Salvador-Bo,J. Cruz,M. Arumi, A. M. Luna,J. A. Guerra,M. Vidal,O. Martinez-Saez,L. Pare,B. Gonzalez-Farre,E. Sanfeliu,E. Ciruelos,M. Espinosa-Bravo,S. Pernas,Y. Izarzugaza,S. Esker,P. -D Fan, P. Parul,A. Santhanagopal,D. Sellami,G. Villacampa,J. M. Ferrero-Cafiero,T. Pascual,A. Prat

ANNALS OF ONCOLOGY（2023）

Cited 10|Views25
Key words
CelTIL score,HER3-DXd,patritumab deruxtecan,HER3,ER883,breast cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined